Hattori Y, Jojima T, Tomizawa A, Satoh H, Hattori S, Kasai K, Hayashi T: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
Higher doses don't increase fat oxidation beyond what the liver's methylation pathways can process
The loss of fat from these areas can lead to increased pressure on bony prominences, causing pain, discomfort, and potential complications
[1] [2] Persistent gastrointestinal symptoms can lead to reduced nutritional intake, dehydration, and electrolyte disturbances, all of which may present as fatigue
GLP-1 has beneficial effects on cardiovascular health, including reducing blood pressure and improving lipid levels